Swedencare AB (publ) (SWDCF)
Swedencare AB (publ) operates in the Drug Manufacturers - Specialty & Generic industry of the Healthcare sector, headquartered in Malmö, SN, SE. The stock last traded at $2.30, up 0.00% on the session, giving a market capitalisation of $367.6M. On trailing twelve-month figures it carries a trailing P/E of 42.70, a net margin of 2.9%. Its beta of 0.57 implies it has historically moved less than the broad market.
Swedencare AB (publ) focuses on the creation, production, and sale of healthcare solutions for animals. A key offering is the ProDen PlaqueOff range, which provides various dental care products like powders, chewable bites, and bones, specifically formulated to reduce plaque and tartar buildup in cats and dogs. Beyond oral health, the company supplies a broad assortment of NutriScience dietary supplements for felines, canines, and equines. These supplements address diverse needs, including supporting joint cartilage, bones, muscles, ligaments, and sinews (e.g., Glucosamine, Stomax, ArthriAid), providing calming effects for anxious dogs (KalmAid), and improving skin and coat condition (OmegaAid, RevitalAid). Swedencare also manufactures specialized supplements for horses, such as Gastrocare for digestive relief, Equine Gold for overall well-being, ArthriAid for cartilage support, and AnxiKalm to soothe excitable animals. Interestingly, the company also extends its dental expertise to humans with ProDen PlaqueOff teeth and gums, a natural supplement for oral hygiene. Their products are made available through a wide distribution network including pharmacies, veterinary practices, pet retailers, animal care facilities, and online platforms. Established in 1993, Swedencare AB (publ) is headquartered in Malmö, Sweden.
Swedencare AB (publ) is most often compared with the following Healthcare names: